Go to main content
Global

Product Overview

AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.

Critical Care

Argipressin AOP

Argipressin AOP is used to treat diabetes insipidus and bleeding from enlarged veins in the oesophagus.

Drug Facts
Active Ingredient
Argipressin
Critical Care

Esmolol®

Esmolol® is indicated for supraventricular tachycardia and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.

Drug Facts
Active Ingredient
Esmolol Hydrochloride
Critical Care

Naloxone

Naloxone hydrochloride is for complete or partial reversal of CNS and especially respiratory depression, caused by natural or synthetic opioids.

Drug Facts
Active Ingredient
Naloxone Hydrochloride Dihydrate